Literature DB >> 11021531

Differences that matter: major cytotoxic T cell-stimulating minor histocompatibility antigens.

S Malarkannan1, T Horng, P Eden, F Gonzalez, P Shih, N Brouwenstijn, H Klinge, G Christianson, D Roopenian, N Shastri.   

Abstract

Despite thousands of genetic polymorphisms among MHC matched mouse strains, a few unknown histocompatibility antigens are targeted by the cytotoxic T cells specific for tissue grafts. We isolated the cDNA of a novel BALB.B antigen gene that defines the polymorphic H28 locus on chromosome 3 and yields the naturally processed ILENFPRL (IFL8) peptide for presentation by Kb MHC to C57BI/6 CTL. The CTL specific for the IFL8/Kb and our previously identified H60/Kb complexes represent a major fraction of the B6 anti-BALB.B immune response. The immunodominance of these antigens can be explained by their differential transcription in the donor versus the host strains and their expression in professional donor antigen-presenting cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11021531     DOI: 10.1016/s1074-7613(00)00033-9

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  24 in total

1.  A single nucleotide polymorphism in the Emp3 gene defines the H4 minor histocompatibility antigen.

Authors:  Brianna Luedtke; Laura M Pooler; Eun Young Choi; Angela M Tranchita; Corbett J A Reinbold; Aaron C Brown; Daniel J Shaffer; Derry C Roopenian; Subramaniam Malarkannan
Journal:  Immunogenetics       Date:  2003-07-04       Impact factor: 2.846

2.  Sensitization to minor antigens is a significant barrier in bone marrow transplantation and is prevented by CD154:CD40 blockade.

Authors:  H Xu; Y Huang; L R Hussain; Z Zhu; L D Bozulic; C Ding; J Yan; S T Ildstad
Journal:  Am J Transplant       Date:  2010-07       Impact factor: 8.086

3.  Remodeling specific immunity by use of MHC tetramers: demonstration in a graft-versus-host disease model.

Authors:  Barry J Kappel; Javier Pinilla-Ibarz; Adam A Kochman; Jeffrey M Eng; Vanessa M Hubbard; Ingrid Leiner; Eric G Pamer; Glen Heller; Marcel R M van den Brink; David A Scheinberg
Journal:  Blood       Date:  2005-11-03       Impact factor: 22.113

4.  Distributions of single nucleotide polymorphisms in differential chromosome segments of congenic resistant strains that define minor histocompatibility antigens.

Authors:  Peter J Wettstein; Nancy D Borson
Journal:  Immunogenetics       Date:  2007-05-31       Impact factor: 2.846

Review 5.  Characterizing and optimizing immune responses to leukaemia antigens after allogeneic stem cell transplantation.

Authors:  Katayoun Rezvani; A John Barrett
Journal:  Best Pract Res Clin Haematol       Date:  2008-09       Impact factor: 3.020

6.  Major and minor histocompatibility antigens to NIMA: Prediction of a tolerogenic NIMA effect.

Authors:  Masahiro Hirayama; Eiichi Azuma
Journal:  Chimerism       Date:  2011-01

7.  Immune Surveillance by Natural IgM Is Required for Early Neoantigen Recognition and Initiation of Adaptive Immunity.

Authors:  Shaikh M Atif; Sophie L Gibbings; Elizabeth F Redente; Faye A Camp; Raul M Torres; Ross M Kedl; Peter M Henson; Claudia V Jakubzick
Journal:  Am J Respir Cell Mol Biol       Date:  2018-11       Impact factor: 6.914

8.  Memory T cells from minor histocompatibility antigen-vaccinated and virus-immune donors improve GVL and immune reconstitution.

Authors:  Ning Li; Catherine Matte-Martone; Hong Zheng; Weiguo Cui; Srividhya Venkatesan; Hung Sheng Tan; Jennifer McNiff; Anthony J Demetris; Derry Roopenian; Susan Kaech; Warren D Shlomchik
Journal:  Blood       Date:  2011-09-13       Impact factor: 22.113

9.  Neurons preferentially respond to self-MHC class I allele products regardless of peptide presented.

Authors:  Nathalie Escande-Beillard; Lorraine Washburn; Dan Zekzer; Zhongqi-Phyllis Wu; Shoshy Eitan; Sonja Ivkovic; Yuxin Lu; Hoa Dang; Blake Middleton; Tina V Bilousova; Yoshitaka Yoshimura; Christopher J Evans; Sebastian Joyce; Jide Tian; Daniel L Kaufman
Journal:  J Immunol       Date:  2009-12-16       Impact factor: 5.422

10.  NKG2D receptor-mediated NK cell function is regulated by inhibitory Ly49 receptors.

Authors:  Jeyarani Regunathan; Yuhong Chen; Demin Wang; Subramaniam Malarkannan
Journal:  Blood       Date:  2004-08-24       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.